相关实验视频

Updated: May 5, 2026

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity

Published on: June 7, 2017

向RARγ降低了免疫抑制性巨细胞偏振,并减少了瘤生长

Jihyeon Park¹, Jisun Oh², Sang-Hyun Min³

¹College of Pharmacy, Kyungpook National University, Daegu 41566, Republic of Korea.

Molecules (Basel, Switzerland)

|August 14, 2025

概括

准视网红酸受体玛 (RARγ) 重编程免疫抑制性瘤相关巨细胞 (TAMs). 抑制RARγ降低了免疫抑制标记物,并阻碍了癌细胞的增殖,提供了一个新的抗癌策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

瘤相关巨细胞 (TAMs) 是瘤微环境 (TME) 中的关键参与者,促进瘤生长和治疗耐药性.
TAMs经常显示免疫抑制的M2类表型,阻碍抗瘤免疫反应.
调节TAM活动对于改善癌症治疗结果至关重要.

研究的目的:

确定TAMs中免疫抑制两极化的关键调节者.
调查视网酸受体 (RARγ) 在TAM功能中的作用.
评估RARγ抑制作为一种潜在的治疗策略来对抗癌症.

主要方法:

利用THP-1巨细胞研究免疫抑制两极化.
使用小分子抑制剂和基因沉默来抑制RARγ.
评估了免疫抑制性巨细胞标记物的表达.
使用一个三维瘤球形模型与HCT116结直肠癌细胞.

主要成果:

网红酸受体玛 (RARγ) 被确定为免疫抑制性巨细胞两极分化的关键调节者.
抑制RARγ显著降低了免疫抑制性巨细胞标记物的表达.
在瘤球形模型中,RARγ抑制阻碍了结直肠癌细胞的增殖.

结论:

向RARγ将免疫抑制TAM重编程到一个不太促进瘤的表型.
抑制RARγ可以减轻TAMs的前瘤性影响.
RARγ 是一种新型抗癌策略的有前途的治疗标.

关键词:

在M2中,极化为M2.网红酸受体玛受体是什么?治疗目标是治疗的目标.瘤微环境是一个微环境.与瘤相关的巨细胞.

更多相关视频

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.